In accordance with current guidelines recommending comprehensive evaluation for Budd-Chiari syndrome, even when a known risk factor exists, genetic testing was performed and revealed heterozygosity for the factor V Leiden mutation, an inherited thrombophilia likely contributing to thrombosis in this patient. Here, F5 is linked to hepatic veno-occlusive disease.